Run-Jing Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Run-Jing Li has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Cui Yang
Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China
1 shared publication - Feng Fu
Department of Physiology and Pathophysiology, National Key Discipline of Cell Biology, Fourth Military Medical University, China; Department of Cardiology, Tangdu Hospital, Fourth Military Medical University, China
1 shared publication - Hong-Wei Chen
Department of Cardiology
1 shared publication - Jia-Jia Xu
Department of Cardiology
1 shared publication - Min-Wei Chen
Department of Cardiology
1 shared publication - Mingge Ding
Department of Geriatrics Cardiology, The Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, 710004, China
1 shared publication
Latest Publications
- 12 December 2023
- Published by Wolters Kluwer Health in Circulation
- Vol. 148 (24) , 1979
Letter by Li et al Regarding Article, “Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy”
- 12 December 2023
- Published by Wolters Kluwer Health in Circulation
- Vol. 148 (24) , 1979
Letter by Li et al Regarding Article, “Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy”
- Open Access
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 1115749
Inhibition of GSDMD Activates Poly(ADP‐ribosyl)ation and Promotes Myocardial Ischemia‐Reperfusion Injury
The precise control of cardiomyocyte viability is imperative to combat myocardial ischemia‐reperfusion injury (I/R), in which apoptosis and pyroptosis putatively contribute to the process. Recent researches indicated that GSDMD is involved in I/R as an executive protein of pyroptosis. However, its effect on other forms of cell death is unclear. We identified that GSDMD and GSDMD‐N levels were significantly upregulated in the I/R myocardium of mice. Knockout of GSDMD conferred the resistance of the hearts to reperfusion injury in the acute phase of I/R but aggravated reperfusion injury in the chronic phase of I/R. Mechanistically, GSDMD deficiency induced the activation of PARylation and the consumption of NAD+ and ATP, leading to cardiomyocyte apoptosis. Moreover, PJ34, a putative PARP‐1 inhibitor, reduced the myocardial injury caused by GSDMD deficiency. Our results reveal a novel action modality of GSDMD in the regulation of cardiomyocyte death; inhibition of GSDMD activates PARylation, suggesting the multidirectional role of GSDMD in I/R and providing a new theory for clinical treatment.
- 1 January 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 1115749
Open AccessInhibition of GSDMD Activates Poly(ADP‐ribosyl)ation and Promotes Myocardial Ischemia‐Reperfusion Injury
The precise control of cardiomyocyte viability is imperative to combat myocardial ischemia‐reperfusion injury (I/R), in which apoptosis and pyroptosis putatively contribute to the process. Recent researches indicated that GSDMD is involved in I/R as an executive protein of pyroptosis. However, its effect on other forms of cell death is unclear. We identified that GSDMD and GSDMD‐N levels were significantly upregulated in the I/R myocardium of mice. Knockout of GSDMD conferred the resistance of the hearts to reperfusion injury in the acute phase of I/R but aggravated reperfusion injury in the chronic phase of I/R. Mechanistically, GSDMD deficiency induced the activation of PARylation and the consumption of NAD+ and ATP, leading to cardiomyocyte apoptosis. Moreover, PJ34, a putative PARP‐1 inhibitor, reduced the myocardial injury caused by GSDMD deficiency. Our results reveal a novel action modality of GSDMD in the regulation of cardiomyocyte death; inhibition of GSDMD activates PARylation, suggesting the multidirectional role of GSDMD in I/R and providing a new theory for clinical treatment.